FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2101116196> ?p ?o ?g. }

• W2101116196 endingPage "620" @default.
• W2101116196 startingPage "619" @default.
• W2101116196 abstract "HomeRadiologyVol. 271, No. 2 PreviousNext CommunicationsLetters to the EditorIs Volumetric Functional MR Imaging Superior to Current Anatomic Imaging Response Criteria for Hepatocellular Carcinoma after Intraarterial Therapy?Xiao-Dan Ye*, Wen-Tao Li†, Zheng Yuan‡ Xiao-Dan Ye*, Wen-Tao Li†, Zheng Yuan‡ Author AffiliationsDepartment of Radiology, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China*Department of Radiology, Shanghai Cancer Hospital, Fudan University, Shanghai, China†Department of Radiology, Shanghai No. 85 Hospital, 1328 Hua Shan Rd, Shanghai 200032, China‡e-mail: [email protected]Xiao-Dan Ye*Wen-Tao Li†Zheng Yuan‡ Published Online:May 1 2014https://doi.org/10.1148/radiol.14132533MoreSectionsFull textPDF ToolsImage ViewerAdd to favoritesCiteTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinked In References1. Bonekamp S, Halappa VG, Geschwind JF, et al. Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. II. Response stratification using volumetric functional criteria after intraarterial therapy. Radiology 2013;268(2):431–439. Link, Google Scholar2. Yuan Z, Li WT, Peng WJ. Pre-treatment apparent diffusion coefficient is imaging biomarker for prediction of response to chemoembolization in hepatocellular carcinoma. Eur J Radiol 2013;82(12):e901–e902. Crossref, Medline, Google Scholar3. Yuan Z, Ye XD, Dong S, et al. Role of magnetic resonance diffusion-weighted imaging in evaluating response after chemoembolization of hepatocellular carcinoma. Eur J Radiol 2010;75(1):e9–e14. Crossref, Medline, Google Scholar4. Dong S, Ye XD, Yuan Z, et al. Relationship of apparent diffusion coefficient to survival for patients with unresectable primary hepatocellular carcinoma after chemoembolization. Eur J Radiol 2012;81(3):472–477. Crossref, Medline, Google Scholar5. Song MJ, Chun HJ, Song Do S, et al. Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma. J Hepatol 2012;57(6):1244–1250. Crossref, Medline, Google Scholar6. Sacco R, Bargellini I, Bertini M, et al. Conventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma. J Vasc Interv Radiol 2011;22(11):1545–1552. Crossref, Medline, Google Scholar7. Kim BK, Kim SU, Kim MJ, et al. Number of target lesions for EASL and modified RECIST to predict survival in hepatocellular carcinoma treated with chemoembolization. Clin Cancer Res 2013;19(6):1503–1511. Crossref, Medline, Google Scholar8. Gillmore R, Stuart S, Kirkwood A, et al. EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization. J Hepatol 2011;55(6):1309–1316. Crossref, Medline, Google ScholarArticle HistoryPublished online: May 2014Published in print: May 2014 FiguresReferencesRelatedDetailsCited ByRadiological biomarkers for assessing response to locoregional therapies in hepatocellular carcinoma: From morphological to functional imagingXiao-DanYe, ZuguoYuan, JianZhang, ZhengYuan2017 | Oncology Reports, Vol. 37, No. 3Diffusion-Weighted MR Imaging of Hepatocellular Carcinoma: Current Value in Clinical Evaluation of Tumor Response to Locoregional TreatmentZhengYuan, JianZhang, HuanYang, Xiao-DanYe, Li-ChaoXu, Wen-TaoLi2016 | Journal of Vascular and Interventional Radiology, Vol. 27, No. 1Recommended Articles Imaging Biomarkers of Tumor Response in Neuroendocrine Liver Metastases Treated with Transarterial Chemoembolization: Can Enhancing Tumor Burden of the Whole Liver Help Predict Patient Survival?Radiology2016Volume: 283Issue: 3pp. 883-894Lack of Response to Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: Abandon or Repeat?Radiology2021Volume: 298Issue: 3pp. 680-692Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular CarcinomaRadiology2019Volume: 292Issue: 1pp. 237-247Early Sorafenib-related Biomarkers for Combination Treatment with Transarterial Chemoembolization and Sorafenib in Patients with Hepatocellular CarcinomaRadiology2017Volume: 284Issue: 2pp. 583-592Chemical Shift MRI Monitoring of Chemoembolization Delivery for Hepatocellular Carcinoma: Multicenter Feasibility of Initial Clinical TranslationRadiology: Imaging Cancer2023Volume: 5Issue: 3See More RSNA Education Exhibits Common Patterns of Change in ADC Histogram of Hepatocellular Carcinoma Lesions Following Transarterial Chemoembolization and Their Relationship with Patients’ PrognosisDigital Posters2019Treatment Response Assessment After Radiation Therapy For Hepatocellular Carcinoma (HCC): Diagnostic ChallengesDigital Posters2021Response Evaluation Criteria in GI Cancers: What to Use and How to Measure: An Emerging Challenge in the Era of Novel Cancer TreatmentsDigital Posters2022 RSNA Case Collection Hepatic AdenomatosisRSNA Case Collection2021LI-RADS 5RSNA Case Collection2022Radioembolization of Liver Metastasis RSNA Case Collection2020 Vol. 271, No. 2 Metrics Altmetric Score PDF download" @default.
• W2101116196 created "2016-06-24" @default.
• W2101116196 creator A5015425896 @default.
• W2101116196 creator A5015887741 @default.
• W2101116196 creator A5028334189 @default.
• W2101116196 date "2014-05-01" @default.
• W2101116196 modified "2023-10-16" @default.
• W2101116196 title "Is Volumetric Functional MR Imaging Superior to Current Anatomic Imaging Response Criteria for Hepatocellular Carcinoma after Intraarterial Therapy?" @default.
• W2101116196 cites W2031009337 @default.
• W2101116196 cites W2053755320 @default.
• W2101116196 cites W2086804632 @default.
• W2101116196 cites W2093056352 @default.
• W2101116196 cites W2100969474 @default.
• W2101116196 cites W2113694705 @default.
• W2101116196 cites W2142426633 @default.
• W2101116196 cites W2143316144 @default.
• W2101116196 doi "https://doi.org/10.1148/radiol.14132533" @default.
• W2101116196 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24761959" @default.
• W2101116196 hasPublicationYear "2014" @default.
• W2101116196 type Work @default.
• W2101116196 sameAs 2101116196 @default.
• W2101116196 citedByCount "2" @default.
• W2101116196 countsByYear W21011161962016 @default.
• W2101116196 countsByYear W21011161962017 @default.
• W2101116196 crossrefType "journal-article" @default.
• W2101116196 hasAuthorship W2101116196A5015425896 @default.
• W2101116196 hasAuthorship W2101116196A5015887741 @default.
• W2101116196 hasAuthorship W2101116196A5028334189 @default.
• W2101116196 hasConcept C126322002 @default.
• W2101116196 hasConcept C126838900 @default.
• W2101116196 hasConcept C143409427 @default.
• W2101116196 hasConcept C2778019345 @default.
• W2101116196 hasConcept C2989005 @default.
• W2101116196 hasConcept C71924100 @default.
• W2101116196 hasConceptScore W2101116196C126322002 @default.
• W2101116196 hasConceptScore W2101116196C126838900 @default.
• W2101116196 hasConceptScore W2101116196C143409427 @default.
• W2101116196 hasConceptScore W2101116196C2778019345 @default.
• W2101116196 hasConceptScore W2101116196C2989005 @default.
• W2101116196 hasConceptScore W2101116196C71924100 @default.
• W2101116196 hasIssue "2" @default.
• W2101116196 hasLocation W21011161961 @default.
• W2101116196 hasLocation W21011161962 @default.
• W2101116196 hasOpenAccess W2101116196 @default.
• W2101116196 hasPrimaryLocation W21011161961 @default.
• W2101116196 hasRelatedWork W1981897771 @default.
• W2101116196 hasRelatedWork W2049214470 @default.
• W2101116196 hasRelatedWork W2071330355 @default.
• W2101116196 hasRelatedWork W2155760687 @default.
• W2101116196 hasRelatedWork W2418341674 @default.
• W2101116196 hasRelatedWork W2526999821 @default.
• W2101116196 hasRelatedWork W2901407291 @default.
• W2101116196 hasRelatedWork W2902148150 @default.
• W2101116196 hasRelatedWork W4235693741 @default.
• W2101116196 hasRelatedWork W2183494712 @default.
• W2101116196 hasVolume "271" @default.
• W2101116196 isParatext "false" @default.
• W2101116196 isRetracted "false" @default.
• W2101116196 magId "2101116196" @default.
• W2101116196 workType "article" @default.